Enhanced Neural Activity Detection and Suppression System using Synergistic Combinations

The present inventive concept integrates acoustic waves and/or ultrasound with distinct technologies such as AI, IoT, blockchain, and new materials to create a more powerful system for detecting, localizing, and suppressing neural activity, particularly in epilepsy treatment.

The original patent disclosed a method for detecting, localizing, and suppressing neural activity using acoustic waves and/or ultrasound. However, the method had limitations in terms of detection accuracy, real-time feedback, and secure data storage. The present inventive concept addresses these limitations by incorporating synergistic combinations of technologies to enhance the system's overall performance.

The enhanced system comprises multiple modules, including a neural activity detection module integrated with an AI-powered seizure prediction algorithm, a real-time feedback mechanism, and an IoT-enabled communication module for transmitting neural activity data to a cloud-based server. Additionally, the system incorporates a novel graphene-based ultrasonic transducer and a blockchain-based system for securely storing and sharing neural activity data. The system also enables synergistic combinations of ultrasound and transcranial magnetic stimulation (TMS) to enhance suppression of neural activity.

The present inventive concept introduces novel combinations of technologies, including AI-powered seizure prediction, IoT-enabled communication, blockchain-based secure data storage, and graphene-based ultrasonic transducers, which provide a significant improvement over the original patent. The inventive step lies in the integration of these distinct technologies to create a more powerful and efficient system for detecting, localizing, and suppressing neural activity.

Alternative embodiments of the inventive concept may include variations in the AI-powered seizure prediction algorithm, the type of blockchain-based system used, or the materials used for the ultrasonic transducers. Additionally, the system could be integrated with other technologies such as machine learning or computer vision to further enhance its performance.

The enhanced system has significant commercial potential in the medical device industry, particularly in the treatment of epilepsy and other neurological disorders. The system's ability to provide real-time feedback and secure data storage makes it an attractive solution for healthcare providers and patients. The market for such a system is substantial, with an estimated value of billions of dollars.